|
Market Cap | 821.59M | EPS (ttm) | 0.51 |
P/E | 19.35 | EPS this Y | -12.00% |
Forward P/E | 11.66 | EPS next Y | 0.10% |
PEG | - | EPS past 5Y | 24.78% |
P/S | 0.70 | EPS next 5Y | -4.20% |
P/B | 4.07 | EPS Q/Q | -17.55% |
Dividend | - | Sales Q/Q | 2.94% |
Insider Own | 40.07% | Inst Own | 50.49% |
Insider Trans | -1.45% | Inst Trans | -2.83% |
Short Float | 2.31% | Earnings | May 08/a |
Analyst Recom | 1.00 | Target Price | 14.33 |
Avg Volume | 296.59K | 52W Range | 9.37 - 12.05 |
|
|
|
Accel Entertainment, Inc. operates as a distributed gaming operator. It is involved in the installation, maintenance, and operation of gaming terminals, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and other amusement devices in authorized non-casino locations, such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. It also provides licensed establishment partners gaming solutions that appeal to players who patronize those businesses. In addition, the firm operates stand-alone ATMs in gaming and non-gaming locations, as well as amusement devices, including jukeboxes, dartboards, pool tables, pinball machines, and other related entertainment equipment. The company was founded by Andrew Rubenstein and Gordon Rubenstein on December 8, 2010 and is headquartered in Burr Ridge, IL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Harmer Derek | Secretary | Jun 16 '24 | Option Exercise | 0.00 | 2,021 | 0 | 193,397 | Jun 18 07:09 PM | Ellis Mathew Scot | Chief Financial Officer | Jun 16 '24 | Option Exercise | 0.00 | 737 | 0 | 53,180 | Jun 18 07:11 PM | Rubenstein Andrew H. | CEO and President | Jun 16 '24 | Option Exercise | 0.00 | 5,614 | 0 | 4,250,416 | Jun 18 07:19 PM | Harmer Derek | Secretary | Jun 14 '24 | Option Exercise | 0.00 | 1,846 | 0 | 191,917 | Jun 18 07:09 PM | Ellis Mathew Scot | Chief Financial Officer | Jun 14 '24 | Option Exercise | 0.00 | 796 | 0 | 52,677 | Jun 18 07:11 PM |
|
|
|
|
Market Cap | 261.75M | EPS (ttm) | -2.76 |
P/E | - | EPS this Y | 35.76% |
Forward P/E | - | EPS next Y | 16.41% |
PEG | - | EPS past 5Y | 84.52% |
P/S | 3.81 | EPS next 5Y | 15.80% |
P/B | - | EPS Q/Q | 23.23% |
Dividend | - | Sales Q/Q | -4.94% |
Insider Own | 20.15% | Inst Own | 40.27% |
Insider Trans | -0.32% | Inst Trans | 4.65% |
Short Float | 1.28% | Earnings | May 06/b |
Analyst Recom | 1.43 | Target Price | 10.00 |
Avg Volume | 600.55K | 52W Range | 0.36 - 6.04 |
|
|
|
ADC Therapeutics SA is a clinical-stage biotechnology company. It engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Sandor Victor | Director | Jun 17 '24 | Sale | 2.89 | 6,995 | 20,216 | 80,886 | Jun 18 09:37 PM | Squarer Ron | Director | Jun 17 '24 | Sale | 2.89 | 6,995 | 20,216 | 80,663 | Jun 18 09:35 PM | BIZZARI JEAN-PIERRE | Director | Jun 17 '24 | Sale | 2.89 | 6,995 | 20,216 | 79,502 | Jun 18 09:43 PM | Azelby Robert | Director | Jun 17 '24 | Sale | 2.89 | 6,995 | 20,216 | 53,005 | Jun 18 09:45 PM | Monges Viviane | Director | Jun 17 '24 | Sale | 2.89 | 1,437 | 4,153 | 106,627 | Jun 18 09:40 PM |
|
|
|
|
Market Cap | 57.22B | EPS (ttm) | 4.94 |
P/E | 53.04 | EPS this Y | 15.89% |
Forward P/E | 23.03 | EPS next Y | 12.01% |
PEG | 4.82 | EPS past 5Y | 5.38% |
P/S | 5.46 | EPS next 5Y | 11.00% |
P/B | 5.06 | EPS Q/Q | 22.24% |
Dividend | 0.92% | Sales Q/Q | 20.41% |
Insider Own | 1.14% | Inst Own | 86.23% |
Insider Trans | -5.57% | Inst Trans | 1.87% |
Short Float | 1.24% | Earnings | Apr 25/a |
Analyst Recom | 2.05 | Target Price | 266.24 |
Avg Volume | 820.95K | 52W Range | 209.39 - 262.50 |
|
|
|
Arthur J. Gallagher & Co. engages in the provision of insurance brokerage, reinsurance brokerage, consulting, and third-party claims settlement and administration services. It operates through the following business segments: Brokerage, Risk Management, and Corporate. The Brokerage segment consists of retail and wholesale insurance brokerage operations. The Risk Management segment provides contract claim settlement and administration services. The Corporate segment manages clean energy and other investments. The company was founded by Arthur J. Gallagher in 1927 and is headquartered in Rolling Meadows, IL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Hudson Scott R | Vice President | Jun 18 '24 | Sale | 263.45 | 10,000 | 2,634,530 | 93,730 | Jun 18 06:51 PM | Bay Walter D. | General Counsel | Jun 18 '24 | Sale | 262.74 | 8,303 | 2,181,547 | 36,388 | Jun 18 06:48 PM | JOHNSON DAVID S | Director | May 22 '24 | Sale | 257.84 | 850 | 219,164 | 45,108 | May 24 04:46 PM | Bay Walter D. | General Counsel | May 20 '24 | Option Exercise | 70.74 | 800 | 56,592 | 45,491 | May 20 08:42 PM | Bay Walter D. | General Counsel | May 20 '24 | Sale | 257.24 | 800 | 205,792 | 44,691 | May 20 08:42 PM |
|
|
| |
|
Market Cap | 625.35M | EPS (ttm) | -6.13 |
P/E | - | EPS this Y | 2.97% |
Forward P/E | - | EPS next Y | -6.82% |
PEG | - | EPS past 5Y | -19.45% |
P/S | 27.24 | EPS next 5Y | - |
P/B | 13.09 | EPS Q/Q | -3.54% |
Dividend | - | Sales Q/Q | 422.49% |
Insider Own | 11.26% | Inst Own | 97.87% |
Insider Trans | -5.36% | Inst Trans | 4.78% |
Short Float | 18.54% | Earnings | May 09/a |
Analyst Recom | 1.60 | Target Price | 43.78 |
Avg Volume | 365.46K | 52W Range | 13.36 - 27.50 |
|
|
|
AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. It also offers SHM platform that replicate the natural process of somatic hypermutation embedded within the human immune system to rapidly develop a diverse range of therapeutic-grade antibodies in vitro. The company was founded by Andrew B. Cubitt, William J. Boyle, Kevin J. Kinsella, and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
RENTON HOLLINGS | Director | Jun 18 '24 | Sale | 23.16 | 1,950 | 45,162 | 1,950 | Jun 18 08:15 PM | Jain Rita | Director | Jun 15 '24 | Option Exercise | 0.00 | 4,534 | 0 | 4,534 | Jun 18 08:14 PM | RENTON HOLLINGS | Director | Jun 15 '24 | Option Exercise | 0.00 | 3,900 | 0 | 3,900 | Jun 18 08:15 PM | Ware J. Anthony | Director | Jun 15 '24 | Option Exercise | 0.00 | 3,900 | 0 | 7,500 | Jun 18 08:16 PM | Orwin John A | Director | Jun 15 '24 | Option Exercise | 0.00 | 2,035 | 0 | 2,035 | Jun 18 08:15 PM |
|
|
|
|
Market Cap | 106.65B | EPS (ttm) | 7.19 |
P/E | 47.34 | EPS this Y | 13.85% |
Forward P/E | 38.15 | EPS next Y | 12.90% |
PEG | 2.44 | EPS past 5Y | 45.36% |
P/S | 17.54 | EPS next 5Y | 19.40% |
P/B | 13.58 | EPS Q/Q | 44.14% |
Dividend | - | Sales Q/Q | 16.28% |
Insider Own | 18.20% | Inst Own | 69.31% |
Insider Trans | -1.55% | Inst Trans | 1.40% |
Short Float | 1.42% | Earnings | May 07/a |
Analyst Recom | 1.81 | Target Price | 323.42 |
Avg Volume | 2.59M | 52W Range | 148.32 - 341.87 |
|
|
|
Arista Networks, Inc. engages in the business of developing, marketing, and selling cloud networking solutions. The firm is also involved in switching and routing platforms and related network applications. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Scheinman Daniel | Director | Jun 14 '24 | Sale | 328.17 | 1,000 | 328,169 | 37,732 | Jun 18 07:05 PM | Duda Kenneth | CTO and SVP Software Eng. | Jun 13 '24 | Option Exercise | 17.09 | 20,000 | 341,700 | 23,244 | Jun 17 06:23 PM | Duda Kenneth | CTO and SVP Software Eng. | Jun 13 '24 | Sale | 325.88 | 20,000 | 6,517,617 | 3,244 | Jun 17 06:23 PM | Duda Kenneth | CTO and SVP Software Eng. | Jun 13 '24 | Sale | 325.86 | 19,756 | 6,437,723 | 194,844 | Jun 17 06:23 PM | Ullal Jayshree | President and CEO | Jun 04 '24 | Option Exercise | 56.59 | 832 | 47,079 | 18,513 | Jun 06 07:16 PM |
|
|
| |
|
Market Cap | 8.39B | EPS (ttm) | 2.07 |
P/E | 111.72 | EPS this Y | 133.00% |
Forward P/E | 44.82 | EPS next Y | 29.80% |
PEG | 4.47 | EPS past 5Y | -33.29% |
P/S | 12.49 | EPS next 5Y | 25.00% |
P/B | 24.73 | EPS Q/Q | 206.41% |
Dividend | - | Sales Q/Q | 37.71% |
Insider Own | 40.81% | Inst Own | 54.29% |
Insider Trans | -1.74% | Inst Trans | 0.13% |
Short Float | 4.77% | Earnings | Apr 25/a |
Analyst Recom | 1.44 | Target Price | 266.60 |
Avg Volume | 303.25K | 52W Range | 162.32 - 256.73 |
|
|
|
AppFolio, Inc., provides industry-specific cloud-based business software solutions, services, and data analytics for the real estate industry. The firm offers AppFolio Property Manager, a property management solution designed to address the operational and business requirements of property management companies and their business ecosystems and AppFolio Investment Management, a cloud-based software solution for real estate investment managers of various sizes that provides tools and services designed to streamline their real estate investment management businesses. It also provides Value+ services that are designed to enhance, automate, and streamline processes and workflows for property management businesses, such as artificial intelligence leasing assistant, tenant screening, electronic payment, utility management, maintenance contact center, tenant debt collection, and mailing services. The company was founded by Brian Donahoo, Klaus Schauser and Jonathan Walker in 2006 and is headquartered in Santa Barbara, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
DUCA MAURICE J | 10% Owner | Jun 18 '24 | Sale | 231.97 | 2,750 | 637,904 | 49,650 | Jun 18 09:02 PM | DUCA MAURICE J | 10% Owner | Jun 17 '24 | Sale | 229.65 | 2,600 | 597,098 | 52,400 | Jun 18 09:02 PM | KERR JANET | Director | Jun 14 '24 | Sale | 232.33 | 2,500 | 580,818 | 13,180 | Jun 18 05:03 PM | DUCA MAURICE J | 10% Owner | Jun 14 '24 | Sale | 231.20 | 2,100 | 485,526 | 55,000 | Jun 18 09:02 PM | BLISS TIMOTHY K | Director | Jun 12 '24 | Sale | 241.31 | 12,170 | 2,936,800 | 0 | Jun 13 07:27 PM |
|
|
|
|
Market Cap | 699.10M | EPS (ttm) | -3.91 |
P/E | - | EPS this Y | -206.40% |
Forward P/E | - | EPS next Y | 63.07% |
PEG | - | EPS past 5Y | 12.40% |
P/S | 6.15 | EPS next 5Y | - |
P/B | 2.65 | EPS Q/Q | -153.37% |
Dividend | - | Sales Q/Q | -59.11% |
Insider Own | 8.65% | Inst Own | 97.30% |
Insider Trans | -4.20% | Inst Trans | -0.13% |
Short Float | 16.72% | Earnings | May 08/a |
Analyst Recom | 1.00 | Target Price | 74.75 |
Avg Volume | 553.95K | 52W Range | 17.52 - 45.00 |
|
|
|
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Marquet Magda | Director | Jun 14 '24 | Option Exercise | 0.00 | 3,131 | 0 | 3,131 | Jun 18 09:00 PM | BARLOW JAMES F | Director | Jun 14 '24 | Option Exercise | 0.00 | 3,131 | 0 | 13,131 | Jun 18 09:00 PM | FARRELL PETER C | Director | Jun 14 '24 | Option Exercise | 0.00 | 3,131 | 0 | 55,741 | Jun 18 09:00 PM | Marantz Jing L. | Director | Jun 14 '24 | Option Exercise | 0.00 | 3,131 | 0 | 3,131 | Jun 18 09:01 PM | HOLMES EDWARD W | Director | Jun 14 '24 | Option Exercise | 0.00 | 3,131 | 0 | 3,131 | Jun 18 09:01 PM |
|
|
| |
|
Market Cap | 93.65M | EPS (ttm) | 0.42 |
P/E | 42.59 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 168.54% |
P/S | 2.10 | EPS next 5Y | - |
P/B | 0.82 | EPS Q/Q | -99.45% |
Dividend | - | Sales Q/Q | 39.18% |
Insider Own | 49.79% | Inst Own | 44.87% |
Insider Trans | 5.55% | Inst Trans | -0.56% |
Short Float | 0.64% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 10.24K | 52W Range | 15.38 - 24.36 |
|
|
|
AMREP Corp. engages in the real estate businesses. It focuses on the entitlement, development and sale of land for residential, commercial, and industrial uses. The firm operates through the following segments: Land Development, Homebuilding, and Corporate. The company was founded in 1961 and is headquartered in Havertown, PA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
DAHL JAMES H | 10% Owner | Jun 18 '24 | Buy | 18.88 | 10,000 | 188,792 | 398,428 | Jun 18 07:19 PM | DAHL JAMES H | 10% Owner | May 15 '24 | Buy | 20.95 | 4,400 | 92,195 | 388,428 | May 16 04:03 PM | DAHL JAMES H | 10% Owner | May 10 '24 | Buy | 20.97 | 3,200 | 67,115 | 384,028 | May 10 06:03 PM | DAHL JAMES H | 10% Owner | May 07 '24 | Buy | 20.60 | 4,621 | 95,193 | 380,828 | May 08 04:53 PM | DAHL JAMES H | 10% Owner | May 03 '24 | Buy | 20.95 | 10,000 | 209,500 | 376,207 | May 06 08:34 PM |
|
|
|
|
Market Cap | 6.82B | EPS (ttm) | 1.00 |
P/E | 46.69 | EPS this Y | 58.98% |
Forward P/E | 34.04 | EPS next Y | 16.84% |
PEG | 4.21 | EPS past 5Y | 55.68% |
P/S | 4.75 | EPS next 5Y | 11.10% |
P/B | 4.91 | EPS Q/Q | 213.01% |
Dividend | - | Sales Q/Q | 10.78% |
Insider Own | 2.04% | Inst Own | 99.35% |
Insider Trans | -7.96% | Inst Trans | -1.36% |
Short Float | 2.84% | Earnings | May 08/a |
Analyst Recom | 1.40 | Target Price | 53.65 |
Avg Volume | 1.48M | 52W Range | 25.03 - 50.78 |
|
|
|
The AZEK Co., Inc. is a manufacturer of outdoor living products. It operates through two segments: Residential and Commercial. The Residential segment involves composite decking, railing, trim, molding, pergolas, cabanas, and accessories. The Commercial segment focuses on sale of its partition and locker systems, plastic sheeting, and other non-fabricated products for special applications in industrial markets. The company was founded on August 15, 2013 and is headquartered in Chicago, IL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Skelly Jonathan | Pres. Res. & Comm. | Jun 18 '24 | Sale | 46.72 | 12,000 | 560,640 | 190,134 | Jun 18 06:19 PM | Skelly Jonathan | Pres. Res. & Comm. | Jun 14 '24 | Option Exercise | 0.00 | 32,609 | 0 | 213,393 | Jun 18 06:19 PM | Singh Jesse G | CEO and President | May 10 '24 | Sale | 45.97 | 13,000 | 597,550 | 1,070,444 | May 10 04:37 PM | Singh Jesse G | CEO and President | Apr 10 '24 | Sale | 48.30 | 13,000 | 627,958 | 1,083,444 | Apr 12 04:10 PM | Singh Jesse G | CEO and President | Mar 11 '24 | Sale | 47.76 | 13,000 | 620,880 | 1,096,444 | Mar 12 04:24 PM |
|
|
|
|
Market Cap | 19.32B | EPS (ttm) | -1.54 |
P/E | - | EPS this Y | 4.86% |
Forward P/E | 17.95 | EPS next Y | 14.08% |
PEG | - | EPS past 5Y | 11.57% |
P/S | 1.45 | EPS next 5Y | 10.50% |
P/B | 2.67 | EPS Q/Q | -673.79% |
Dividend | 1.33% | Sales Q/Q | -18.30% |
Insider Own | 0.59% | Inst Own | 87.09% |
Insider Trans | -0.06% | Inst Trans | -5.91% |
Short Float | 2.50% | Earnings | Apr 26/b |
Analyst Recom | 2.42 | Target Price | 71.80 |
Avg Volume | 1.84M | 52W Range | 42.81 - 71.32 |
|
|
|
Ball Corp. provides metal packaging for beverages, foods, and household products. It operates through the following business segments: Beverage Packaging North and Central America, Beverage Packaging South America, Beverage Packaging Europe, Middle East and Africa (EMEA), and Aerospace. The Beverage Packaging North and Central America segment includes multi-year supply contracts to fillers of carbonated soft drinks, beer, energy drinks, and other beverages. The Beverage Packaging South America segment includes beverage containers in South America, and the manufacture of substantially all the metal beverage containers in Brazil. The Beverage Packaging EMEA segment consists of metal beverage containers in Europe, and other packaging materials used by the European beer and carbonated soft drink industries. The Aerospace segment provides diversified technical services and products to government agencies, prime contractors, and commercial organizations for a broad range of information warfare, electronic warfare, avionics, intelligence, training, and space system needs. The company was founded by Edmund Burke Ball, Frank Clayton Ball, George A. Ball, Lucius Lorenzo Ball, and William Charles Ball in 1880 and is headquartered in Westminster, CO. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Fisher Daniel William | President & C.E.O. | Jun 15 '24 | Option Exercise | 66.01 | 2,100 | 138,621 | 113,966 | Jun 18 07:12 PM | Mariani Pedro Henrique | Director | May 17 '24 | Sale | 69.90 | 5,000 | 349,486 | 9,844 | May 21 07:16 PM | BRYANT JOHN A | Director | Apr 26 '24 | Option Exercise | 69.80 | 3,025 | 211,145 | 8,872 | Apr 30 07:25 PM | Penegor Todd Allan | Director | Apr 26 '24 | Option Exercise | 69.80 | 3,025 | 211,145 | 6,025 | Apr 30 07:27 PM | NIEKAMP CYNTHIA A | Director | Apr 26 '24 | Option Exercise | 69.80 | 3,025 | 211,145 | 16,872 | Apr 30 07:27 PM |
|
|
|